Theravance Biopharma
TBPH
#6070
Rank
$0.44 B
Marketcap
Cayman Islands
Country
$9.20
Share price
-3.36%
Change (1 day)
-21.10%
Change (1 year)
Categories
Market capitalization of Theravance Biopharma (TBPH)
Market cap: $0.44 Billion
As of April 2024 Theravance Biopharma has a market cap of $0.44 Billion. This makes Theravance Biopharma the world's 6070th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Theravance Biopharma from 2014 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.44 B | -20.18% |
| 2023 | $0.55 B | -25.95% |
| 2022 | $0.75 B | -7.19% |
| 2021 | $0.81 B | -28.76% |
| 2020 | $1.14 B | -22.56% |
| 2019 | $1.47 B | 3.6% |
| 2018 | $1.42 B | -5.57% |
| 2017 | $1.50 B | -8.88% |
| 2016 | $1.65 B | 166.01% |
| 2015 | $0.62 B | 29.49% |
| 2014 | $0.48 B |
End of Day market cap according to different sources
On Apr 18th, 2024 the market cap of Theravance Biopharma was reported to be:
$0.44 Billion
$0.44 Billion
$0.44 Billion
$0.44 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Corcept Therapeutics
CORT | $2.35 B | 426.68% | 🇺🇸 USA |
 Collegium Pharmaceutical
COLL | $1.13 B | 154.54% | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | $1.81 B | 305.21% | 🇺🇸 USA |
 Catalent CTLT | $10.09 B | 2,160.39% | 🇺🇸 USA |